지속적 신대체 요법을 시행받은 급성 신부전증 환자들에서 사망률 예측인자에 대한 분석
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김은정 | - |
dc.contributor.author | 정철호 | - |
dc.contributor.author | 박무용 | - |
dc.contributor.author | 김진국 | - |
dc.contributor.author | 최수정 | - |
dc.contributor.author | 황승덕 | - |
dc.date.accessioned | 2021-08-12T06:46:59Z | - |
dc.date.available | 2021-08-12T06:46:59Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 2211-9132 | - |
dc.identifier.issn | 2211-9140 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/17331 | - |
dc.description.abstract | Purpose: Acute kidney injury (AKI) is a frequent condition with a high mortality rate that requires continuous renal replacement therapy (CRRT). We evaluated the Simplified Acute Physiology Score 3 (SAPS 3) and Acute Physiology and Chronic Health Evaluation II (APACHE II) score, determined at the start of CRRT, for predicting mortality in AKI. Methods: We retrospectively analyzed the demographic, clinical, and laboratory data of 89 patients with AKI or acute-on-chronic kidney disease who received CRRT between September 2006 and September 2009. We calculated the SAPS 3 and APACHE II score at the start of CRRT. Results: The average age of the 89 patients was 64.4±13.9 (17-92) years. Fifty-nine (66.3%) were male. Eighteen (20.2%) patients had chronic kidney disease and 30 (33.7%) had diabetes. The overall mortality was 75.3%. The average SAPS 3 was 89.4±14.9 and the average APACHE II score was 28.4±5.2. The SAPS 3 was higher in non-survivors than survivors (p=0.038). Infection was more common in non-survivors (p=0.036). There were no significant differences between the two groups for other conditions. The variables influencing mortality on univariate analysis were SAPS 3 and presence of infection. The area under the receiver-operating characteristic curve for SAPS 3 was 0.69 (95% CI. 0.54-0.83). At a SAPS 3 of 84, the sensitivity for predicting mortality was 71.6% and the specificity was 69.2%. Conclusion: The SAPS 3 determined before starting CRRT could be a predictor of hospital mortality in patients with AKI. | - |
dc.format.extent | 7 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한신장학회 | - |
dc.title | 지속적 신대체 요법을 시행받은 급성 신부전증 환자들에서 사망률 예측인자에 대한 분석 | - |
dc.title.alternative | Mortality Predictors in Patients Treated with Continuous Renal Replacement | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.bibliographicCitation | Kidney Research and Clinical Practice, v.30, no.1, pp 73 - 79 | - |
dc.citation.title | Kidney Research and Clinical Practice | - |
dc.citation.volume | 30 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 73 | - |
dc.citation.endPage | 79 | - |
dc.identifier.kciid | ART001520648 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Renal replacement therapy | - |
dc.subject.keywordAuthor | Mortality | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.